Vivos Inc. (OTC: RDGL) Reaches Exceptional Growth in 2024

After the company made a major new announcement on December 26, it is quite likely that the Vivos Inc. (OTC: RDGL) stock may come on to the radars of investors this morning. Ahead of the beginning of trading today, investors could do well to look into the updates provided by Vivos this past Friday.

Key Milestones

The company announced that it had managed to make major strides in its IsoPet Animal Cancer Division, and that helped in hitting new milestones in the realm of veterinary care. On top of that, the milestones in question also helped the company in boosting the extent of its certified clinic network in the United States.

In May 2024, the division had been launched by Vivos, and a team of experienced professionals was installed to oversee its expansion. Through the course of the year, the division strengthened its place as the leading player in animal cancer care treatments that used the least invasive methods.

Key Details

The company also announced that it launched a dedicated new website, www.IsoPet.com, in the first fiscal quarter of 2024. The website helped in providing veterinarians and pet owners with research, resources, and live support. It remains to be seen the further progress the division makes in 2025.

A Message from Vivos Inc. CEO, Dr. Michael Korenko

“Over the last two years, we focused on identifying the most effective marketing approaches, and those efforts are now paying off. Our priority for 2025 and 2026 is to expand our network of small animal, equine, and exotic clinics while increasing the number of patients benefiting from IsoPet®’s innovative treatments. Clinics appreciate the low-cost certification process, and pet owners value IsoPet®’s one-time effective therapies.”